Facebook Linkedin RSS Twitter Youtube
Home 2024

Rentschler Biopharma

Rentschler Biopharma’s New Production Line in Massachusetts Now Fully Operational
Bioprocessing

Rentschler Biopharma’s New Production Line in Massachusetts Now Fully Operational

Rentschler Biopharma: Committed to Advancing Cell and Gene Therapies
Bioprocessing

Rentschler Biopharma: Committed to Advancing Cell and Gene Therapies

Rentschler Biopharma’s ATMP Business Facility Receives U.K. Approval
Bioprocessing

Rentschler Biopharma’s ATMP Business Facility Receives U.K. Approval

Urgency Is Needed to Drive Gene Therapy and Bioprocessing
Bioprocessing

Urgency Is Needed to Drive Gene Therapy and Bioprocessing

Rentschler, CGT Catapult, and Refeyn Sign AAV Gene Therapy Agreement
Bioprocessing

Rentschler, CGT Catapult, and Refeyn Sign AAV Gene Therapy Agreement

40th Anniversary Recollections & Predictions
Drug Discovery

40th Anniversary Recollections & Predictions

Rentschler Breaks Ground on New U.S. Production Site
Bioprocessing

Rentschler Breaks Ground on New U.S. Production Site

Rentschler Establishes U.K. Center of Excellence for Cell and Gene Therapy
Bioprocessing

Rentschler Establishes U.K. Center of Excellence for Cell and Gene Therapy

Rentschler Contributes to COVID-19 mRNA Vaccine Manufacture
Bioprocessing

Rentschler Contributes to COVID-19 mRNA Vaccine Manufacture

Rentschler Biopharma Focuses on Reducing Timelines with Process Intensification
Bioprocessing

Rentschler Biopharma Focuses on Reducing Timelines with Process Intensification

123Page 1 of 3
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.